Roivant Sciences Ltd WT (ROIVW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ROIVW | ZVSA | BDRX | ||
| Company | Roivant Sciences Ltd WT | Zyversa Therapeutics Inc | Biodexa Pharmaceuticals Plc ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.86 | 1.1800 | 3.70 | ||
| High | 2.92 | 1.2700 | 3.80 | ||
| Low | 2.75 | 1.1000 | 3.60 | ||
| Last | 2.75 | 1.2400 | 3.65 | ||
| Change | -0.11 | +0.1600 | +0.03 | ||
| % Change | -3.85% | +14.81% | +0.83% | ||
| Volume | 37,800 | 273,900 | 25,400 | ||
| 20-Day Average Volume | 201,870 | 3,570,065 | 53,100 | ||
| Previous Close | 2.86 | 1.0800 | 3.62 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 2.78 | 1.7326 | 5.64 | ||
| 20-Day Raw Stochastic | 39.13% | 8.58% | 3.55% | ||
| 20-Day Relative Strength | 49.75% | 35.00% | 32.23% | ||
| Weighted Alpha | +210.22 | -91.88 | -94.51 | ||
| Today's Opinion | 48% Buy | 100% Sell | 100% Sell | ||
| Previous Opinion | 96% Buy | 100% Sell | 100% Sell | ||
| Last Month's Opinion | 88% Buy | 88% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.10% since 08/25/23 | -4.62% since 11/11/24 | -29.13% since 11/11/24 | ||
| Low | 2.75 on 09/01/23 | 1.0401 on 11/15/24 | 3.51 on 11/15/24 | ||
| High | 2.93 on 08/31/23 | 1.3500 on 11/12/24 | 5.45 on 11/12/24 | ||
| 1-Month | |||||
| %Chg | -15.12% since 08/01/23 | -46.09% since 10/18/24 | -35.96% since 10/18/24 | ||
| Low | 2.57 on 08/17/23 | 1.0401 on 11/15/24 | 3.51 on 11/15/24 | ||
| High | 3.21 on 08/02/23 | 3.3700 on 11/05/24 | 7.45 on 10/23/24 | ||
| 3-Month | |||||
| %Chg | +30.95% since 06/01/23 | -56.03% since 08/16/24 | -75.63% since 08/16/24 | ||
| Low | 1.92 on 06/27/23 | 1.0401 on 11/15/24 | 3.51 on 11/15/24 | ||
| High | 4.00 on 07/06/23 | 3.9600 on 08/22/24 | 16.31 on 08/20/24 | ||
| 6-Month | |||||
| %Chg | +59.88% since 03/01/23 | -72.37% since 05/17/24 | -87.73% since 05/17/24 | ||
| Low | 1.23 on 03/23/23 | 1.0401 on 11/15/24 | 3.51 on 11/15/24 | ||
| High | 4.00 on 07/06/23 | 6.3000 on 07/10/24 | 74.00 on 05/21/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | N/A | 1,112 | 431 | ||
| Shares Outstanding, K | N/A | 1,029 | 119 | ||
| Annual Sales | 124,800,000 | 0 | 410,000 | ||
| Annual Net Income | 4,348,930,000 | -98,300,000 | -7,660,000 | ||
| Last Quarter Sales | 4,475,000 | 0 | N/A | ||
| Last Quarter Net Income | -230,184,000 | -2,760,000 | N/A | ||
| 60-Month Beta | N/A | 0.65 | 1.43 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -3.31 on 08/09/24 | N/A | ||
| Latest Earnings Date | 11/12/24 | 11/12/24 | 04/26/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | N/A | 0.00 | 0.00 | ||